FDA — authorised 9 August 2024
- Application: NDA214697
- Marketing authorisation holder: ARS PHARMS OPERATION
- Local brand name: NEFFY
- Indication: SPRAY — NASAL
- Status: approved
FDA authorised Neffy on 9 August 2024
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 9 August 2024; FDA has authorised it.
ARS PHARMS OPERATION holds the US marketing authorisation.